Dysregulation of Fatty Acid Metabolism in Breast Cancer and Its Targeted Therapy

被引：1

作者：

Chang, Yue ^{[1
,2
]}

Du, Rui ^{[3
]}

Xia, Fan ^{[1
,2
]}

Xu, Xiuli ^{[1
,2
]}

Wang, Hongzhi ^{[1
,2
]}

Chen, Xueran ^{[1
,2
]}

机构：

[1] Chinese Acad Sci, Hefei Canc Hosp, Hefei, Anhui, Peoples R China

[2] Chinese Acad Sci, Inst Hlth & Med Technol, Hefei Inst Phys Sci, Hefei, Anhui, Peoples R China

[3] Anhui Med Univ, Affiliated Hosp 3, Hefei Peoples Hosp 1, Dept Anorectal Surg, Hefei, Anhui, Peoples R China

来源：

BREAST CANCER-TARGETS AND THERAPY | 2024年 / 16卷

关键词：

breast cancer; fatty acid metabolism; metabolic reprogramming; targeted therapy; LIPID-METABOLISM; CELL SURVIVAL; SYNTHASE; APOPTOSIS; SREBP; RESISTANCE; OXIDATION; PROMOTE; LIPOGENESIS; METASTASIS;

D O I：

10.2147/BCTT.S496322

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Breast cancer has become the number one cancer worldwide, there are challenges in its prevention, diagnosis and treatment, especially the pathogenesis of triple negative breast cancer has not been clear and the treatment dilemma of metastatic breast cancer. Metabolic reprogramming is currently considered to be one of the hallmarks of cancer, and metabolic alterations in breast cancer, including enhanced glycolysis, tricarboxylic acid cycle activity, glutamine catabolism, and fatty acid biosynthesis, are manifested differently in different breast cancer subtypes and have a complex relationship with tumor growth, metastasis, death, and drug resistance. At present, inhibitors of fatty acid synthesis and oxidation related enzymes have a certain effect in the treatment of breast cancer. In this paper, we review the studies on fatty acid metabolism in breast cancer to better understand the mechanism of fatty acid metabolism in breast cancer pathogenesis and hope to provide new ideas for targeting fatty acid metabolism in the treatment of breast cancer.

引用

页码：825 / 844

页数：20

共 118 条

[1] ITGA2 promotes expression of ACLY and CCND1 in enhancing breast cancer stemness and metastasis [J].

Adorno-Cruz, Valery ;

Hoffmann, Andrew D. ;

Liu, Xia ;

Dashzeveg, Nurmaa K. ;

Taftaf, Rokana ;

Wray, Brian ;

Keri, Ruth A. ;

Liu, Huiping .

GENES & DISEASES, 2021, 8 (04) :493-508

[2] MCF-7 Drug Resistant Cell Lines Switch Their Lipid Metabolism to Triple Negative Breast Cancer Signature [J].

Adria-Cebrian, Jose ;

Guaita-Esteruelas, Sandra ;

Lam, Eric W. -F. ;

Rodriguez-Balada, Marta ;

Capellades, Jordi ;

Girona, Josefa ;

Jimenez-Santamaria, Ana Maria ;

Yanes, Oscar ;

Masana, Luis ;

Guma, Josep .

CANCERS, 2021, 13 (23)

[3] What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg [J].

Alexa-Stratulat, Teodora ;

Pesic, Milica ;

Gasparovic, Ana Cipak ;

Trougakos, Ioannis P. ;

Riganti, Chiara .

DRUG RESISTANCE UPDATES, 2019, 46

[4] PGC-1α Promotes Breast Cancer Metastasis and Confers Bioenergetic Flexibility against Metabolic Drugs [J].

Andrzejewski, Sylvia ;

Klimcakova, Eva ;

Johnson, Radia M. ;

Tabaries, Sebastien ;

Annis, Matthew G. ;

McGuirk, Shawn ;

Northey, Jason J. ;

Chenard, Valerie ;

Sriram, Urshila ;

Papadopoli, David J. ;

Siegel, Peter M. ;

St-Pierre, Julie .

CELL METABOLISM, 2017, 26 (05) :778-+

[5] Lipid Metabolism Heterogeneity and Crosstalk with Mitochondria Functions Drive Breast Cancer Progression and Drug Resistance [J].

Azam, Aurelien ;

Sounni, Nor Eddine .

CANCERS, 2022, 14 (24)

[6] Heterogeneity of fatty acid metabolism in breast cancer cells underlies differential sensitivity to palmitate-induced apoptosis [J].

Balaban, Seher ;

Lee, Lisa S. ;

Varney, Bianca ;

Aishah, Atqiya ;

Gao, Quanqing ;

Shearer, Robert F. ;

Saunders, Darren N. ;

Grewal, Thomas ;

Hoy, Andrew J. .

MOLECULAR ONCOLOGY, 2018, 12 (09) :1623-1638

[7] Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration [J].

Balaban, Seher ;

Shearer, Robert F. ;

Lee, Lisa S. ;

van Geldermalsen, Michelle ;

Schreuder, Mark ;

Shtein, Harrison C. ;

Cairns, Rose ;

Thomas, Kristen C. ;

Fazakerley, Daniel J. ;

Grewal, Thomas ;

Holst, Jeff ;

Saunders, Darren N. ;

Hoy, Andrew J. .

CANCER & METABOLISM, 2017, 5

[8] Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells [J].

Bandyopadhyay, S ;

Zhan, R ;

Wang, Y ;

Pai, SK ;

Hirota, S ;

Hosobe, S ;

Takano, Y ;

Saito, K ;

Furuta, E ;

Iiizumi, M ;

Mohinta, S ;

Watabe, M ;

Chalfant, C ;

Watabe, K .

CANCER RESEARCH, 2006, 66 (11) :5934-5940

[9] Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomas [J].

Bjorklund, Sunniva Stordal ;

Kristensen, Vessela N. ;

Seiler, Michael ;

Kumar, Surendra ;

Alnaes, Grethe I. Grenaker ;

Ming, Yao ;

Kerrigan, John ;

Naume, Bjorn ;

Sachidanandam, Ravi ;

Bhanot, Gyan ;

Borresen-Dale, Anne-Lise ;

Ganesan, Shridar .

BMC CANCER, 2015, 15

[10] Obesity and survival among a cohort of breast cancer patients is partially mediated by tumor characteristics [J].

Blair, Cindy K. ;

Wiggins, Charles L. ;

Nibbe, Andrea M. ;

Storlie, Curt B. ;

Prossnitz, Eric R. ;

Royce, Melanie ;

Lomo, Lesley C. ;

Hill, Deirdre A. .

NPJ BREAST CANCER, 2019, 5 (1)

← 1 2 3 4 5 6 7 8 9 10 →